Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CA.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.453NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.637.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.79NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.32.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.93 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.88 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.106 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.346NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.512NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.349NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.265NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.401NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.362NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.312NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.220NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.142NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.523NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.418NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.389NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used